Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Substituted cyclic imides as potential anti-gout agents.

I H Hall1, J P Scoville, D J Reynolds

  • 1Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, N.C. 27599.

Life Sciences
|January 1, 1990
PubMed
Summary

New cyclic imides effectively lower uric acid levels in mice. These compounds inhibit key enzymes involved in uric acid production, offering potential for treating hyperuricemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Social Deprivation among Children with Inherited Metabolic Disorders.

Irish medical journal·2025
Same author

Development of a model of medication review for use in clinical practice: Bristol medication review model.

BMC medicine·2021
Same author

Collaboration between the military and a charity: delivering care to patients, training to defence medical staff and defence engagement overseas.

BMJ military health·2021
Same author

Postnatal growth rate and adult body weight in mammals: a new approach.

Oecologia·2017
Same author

Annually resolved North Atlantic marine climate over the last millennium.

Nature communications·2016
Same author

The Role of the Environment in Fostering Independence: Conceptual and Methodological Issues in Developing an Instrument.

Topics in stroke rehabilitation·2015

Area of Science:

  • Medicinal Chemistry
  • Biochemistry
  • Pharmacology

Background:

  • Elevated serum uric acid levels (hyperuricemia) are associated with various health issues, including gout.
  • Developing effective and safe treatments for hyperuricemia is a significant medical need.

Purpose of the Study:

  • To investigate the potential of N-substituted cyclic imides as agents for reducing serum uric acid levels.
  • To evaluate the inhibitory effects of these compounds on xanthine dehydrogenase and xanthine oxidase enzymes.

Main Methods:

  • Administration of N-substituted cyclic imides (phthalimide, 2,3-dihydrohalazine-1,4-dione, diphenimide) to normal and hyperuric mice at 20 mg/kg/day for 14 days.
  • Measurement of serum uric acid levels in treated mice.
  • In vitro enzymatic assays to determine the IC50 values against commercial xanthine dehydrogenase and xanthine oxidase.

Related Experiment Videos

Main Results:

  • N-substituted cyclic imides significantly reduced serum uric acid levels in both normal and hyperuric mice.
  • The tested agents demonstrated potent inhibition of xanthine dehydrogenase and xanthine oxidase.
  • Enzyme inhibition (IC50) values ranged from 10(-7) to 10(-8) M.

Conclusions:

  • N-substituted cyclic imides are effective in lowering serum uric acid in vivo.
  • These compounds act as potent inhibitors of xanthine dehydrogenase and xanthine oxidase, suggesting a mechanism for their uricosuric effect.
  • The findings support the potential development of these cyclic imides for managing hyperuricemia.